Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
Développer la qualité dans le champ sanitaire, social et médico-social
Logo
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. EKTERLY (sébétralstat)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • Établissements de santé
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

EKTERLY (sébétralstat)

Medicine - Posted on Feb 19 2026
Active substance (DCI)
  • sébétralstat
history (1)
  • 2/12/26

    EKTERLY (sébétralstat) - Angiooedème héréditaire

    Autorisation d’accès précoce refusée à la spécialité EKTERLY (sébétralstat) dans l'indication « traitement symptomatique des...
    icône flèche
Technical information
ATC code
  • B06AC08
Manufacturer
PHARMA BLUE
Presentation

EKTERLY 300 mg
Plaquette (OPA/Alu/PVC/Alu) - Boîte de 6 comprimés enrobés
(CIP : 34009 303 278 1 4)

All our publications
    Congenital, genetic and rare diseases Drug therapy Immune system diseases - miscellaneous Paediatrics Skin and connective tissue diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
eNq1mE1z2jAQhu/8Co8PvWHz2ZDWkGlp0jKTTCkJ004vGWEvQcRIzkrio7++MiYN6ciTRKAjlv3uenf16MXR2XqRektAQTnr+vWg5nvAYp5Qdtf1xzcX1Y5/1qtEc7Ike7edBLWg3vC9OCVCdP18NZgAYSL4dXX5BfTzgH6v4kV8ModYPrtPSZoG34iYXZEsv8eLlpwm3gLkjCddP1Nye9WLhESdRW/F8V5kJIYo3F3ZX53ftvavR2Eu9gpVJQAvCbszigKz0owVIjDZJxLuOG5K8m1aaVMxAsEVxjAkcjZEvqQJJMYQU5IKsAoyXSXXgMsUZB7EKB7O44WwEidzsh7Bw8Cc9Ce92pdrWa1V6ycn7cZpq9Wut1sdq1C4VypzF/RLhNlts/O+3ug0Q2Ah3EvAdFMVMAGJuoKSSMtGDTlKkjpqERX951PmKA7Cw4ujkFCRpWQTzEVmWyqCRC8Daha4e5H8DW5Q0ynVNftPn6k0Dd+Y9XjHDkcZ52jqc8VkCUIuRraF6HMmYV3eUTvqyfVuFimI48n+4cxM/KGapDS25ZsmkAIhx6NBOd6ckeEzETBGd2j4SVnCV+L4yNlvsaPssy01jaIZJvXbxqluSbttvaN+63kqOXvOFfIMQg0jKg5hzIBN+aF00SNqlnocUDezubVDPCYplBiiqiV19FA++jdnY+9uSxULRtGv5ze2s/JDAW6utz+N0jTp/uuyHZJdcF5P5kuJF3s4T77W7pw2W+/IIvv46LS7lq66EHViqhWagTOTMhMfwnC1WgUzIqqC6HoGU3zl6XBmrMMxaqFR/NRad38CnPiEwjcVGHaU+qQ4X9/WU9td/JKTONQd757fuXBjDIkKDuhFAXxnWB6cH5/0T9bYWdrDZ7xxF2ZrY4mknLlyVGpipvRBZ4vuK7tADYjv0ykt+ShTOpdRWHwQ6lWiMP8Y1Kv8BSggFfg=
EDmdKFgqESF23uLp